Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

DNA diagnosis and the emergence of cancer genetic services in European health care.

European journal of human genetics : EJHG - 1 Jan 1997

Stemerding D, Koch L, Bourret P

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenomatous Polyposis Coli
Share to Breast Neoplasms
Share to Delivery of Health Care
Share to DNA, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Europe

Share to Genetic Diseases, Inborn

Share to Neoplasms

Share to Ovarian Neoplasms

Source

Identifiers

PMID: 9450191

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

DNA diagnosis and the emergence of cancer genetic services in European health care.PMID 9450191Read ↗

Cancer genetics services in Europe.Semantic proximity Read ↗

The changing landscape of hereditary cancer genetic testing.Semantic proximity Read ↗

The changing landscape of genetic testing and its impact on clinical and laboratory services and research in EuropeSemantic proximity Read ↗

Call for action: expanding global access to hereditary cancer genetic testing.Semantic proximity Read ↗

Are we any closer to genetic testing for common malignancies?Semantic proximity Read ↗

Medicare-funded cancer genetic tests: a note of caution.Semantic proximity Read ↗

Bringing onco-innovation to Europe’s healthcare systems: the unexploited potential of biomarker testing, real world evidence and the potential of Tumour Agnostics. The lesson from BRCA1/2 genetic testingSemantic proximity Read ↗

Genomics and the continuum of cancer care.Semantic proximity Read ↗

Your DNA is not your diagnosis: getting diagnoses right following secondary genomic findings.Semantic proximity Read ↗

Clinical applications of genetic technologies to cancer care.Semantic proximity Read ↗

Boosting care and knowledge about hereditary cancer: European Reference Network on Genetic Tumour Risk SyndromesSemantic proximity Read ↗

Europe does it better: molecular testing across a national health care system-the French example.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.